Safety and activity of saquinavir in HIV infection
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 345 (8955), 952-955
- https://doi.org/10.1016/s0140-6736(95)90699-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infectionJournal of Clinical Microbiology, 1994
- Preliminary analysis of the Concorde trialThe Lancet, 1993
- Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinaseAntiviral Research, 1991
- Competitive polymerase chain reaction assay for quantitation of HIV-1 DNA and RNAJournal of Virological Methods, 1991
- An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.Proceedings of the National Academy of Sciences, 1990
- A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle MaturationScience, 1990
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989
- Avoiding false positives with PCRNature, 1989
- HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol -ProteaseScience, 1986